openPR Logo
Press release

In-vitro Colorectal Cancer Screening Tests Market to Reach US$980.6 mn by 2023, Increasing Prevalence of Colorectal Cancer Fuels Demand

02-27-2017 02:57 PM CET | Health & Medicine

Press release from: Transparecny Market Research

/ PR Agency: +1-518-618-1030
In-vitro Colorectal Cancer Screening Tests Market to Reach

A research report on the global in-vitro colorectal cancer screening tests market for by Transparency Market Research (TMR) estimates this market to expand at a CAGR of 7.50% during the period from 2015 and 2023. In 2014, the market stood at US$494.1 mn and it is projected reach a value of US$980.6 mn by the end of the forecast period.The research report is titled “In-vitro Colorectal Cancer Screening Tests Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.”

For Any Queries Get Solutions With A PDF Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3698

Colorectal cancer develops from the colon or rectum due to an abnormal growth of cells with the ability to spread to other parts of a human body. The in-vitro colorectal cancer screening test is a technique to diagnose colorectal cancer in humans. The increased prevalence of colorectal cancer has fuelled the demand for in-vitro colorectal cancer screening tests significantly. The increased trend of rapid and non-invasive diagnostic tools and techniques are also propelling this market remarkably across the world.

In this report, the worldwide in-vitro colorectal cancer screening tests market has been studied on the basis of the test and the pipeline. Based on the test, the market has been categorized into fecal occult blood tests, blood biomarkers tests, and stool biomarkers tests. The fecal occult blood tests segment led the overall market in 2014.

MeScore CRC, Cologic, MarCarePlex, miRSIGN, Colox, PanC – Dx are the major pipeline products in the global market for in-vitro colorectal cancer screening tests, states the research study.

The report also presents an assessment of the global market for in-vitro colorectal cancer screening tests on the basis of its regional distribution. According to the study, the market is spread across Asia Pacific, Latin America, Europe, North America, and the Rest of the World.

North America dominated the overall market in 2014 with a share of 35%. The rising incidence of colorectal cancer, the emergence of non-invasive screening tests, the improved access to healthcare, the growing costs of treatments, and the presence of a favorable reimbursement scenario boosted the North America in-vitro colorectal cancer screening tests market significantly in the recent past. Europe, however, is likely to experience the highest growth over the forecast period.

This easy adoption of screening tests and the infrastructural advancement of the medical and healthcare industry in this region is expected to propel the Europe market for in-vitro colorectal cancer screening tests in the coming years, notes the research study.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/in-vitro-colorectal-cancer-screening-tests-market.html

An analysis of the competitive landscape of the worldwide market for in-vitro colorectal cancer screening tests has also been presented in this study. Analysts have studied the current market hierarchy by evaluating major market participants. As per the study, this market demonstrates a fragmented structure, owing to the presence of a large pool of participants. Abbott Laboratories Inc., Alere Inc., Beckman Coulter Inc., Sysmex Corp., Quest Diagnostics Inc., Epigenomics AG, Exact Sciences Corp., BioTime Inc., CML Healthcare Inc., and Novigenix SA are the leading participants in this market, states the report.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-vitro Colorectal Cancer Screening Tests Market to Reach US$980.6 mn by 2023, Increasing Prevalence of Colorectal Cancer Fuels Demand here

News-ID: 449975 • Views: 227

More Releases from Transparecny Market Research

Particle Size Analyzer Market is Poised to Flourish at A 5.2% Value CAGR From 20 …
The global Particle Size Analyzer market is estimated to attain a valuation of US$ 541.3 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.2% during the forecast period, 2022-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Warranty management software market is projected to exceed the value of US$ 12.6 …
The global Warranty Management Software market is estimated to attain a valuation of US$ 12.68 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 13.5% during the forecast period, 2021-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Dental 3D Printing Market To Surpass Valuation Of US$ 2.9 Bn By 2031
The global Dental 3D Printing market is estimated to attain a valuation of US$ 2.9 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.09% during the forecast period, 2021-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Mobile value added services market is expected to cross the value of US$ 1.8 Trn …
The global Mobile Value Added Services market is estimated to attain a valuation of US$ 1.8 Trn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 10.1% during the forecast period, 2021-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading

All 5 Releases


More Releases for Colorectal

Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which
In-vitro Colorectal Cancer Screening Tests Market- Increasing Prevalence of Colo …
Global In-vitro Colorectal Cancer Screening Tests Market: Snapshot Diagnostic tools have undergone a sea change in the recent decades, owing to the rapidly growing demand for non-invasive diagnostics that are efficient as well as fast. Compliance with these demands ensures that the tools provide a relatively higher ease of operation and also promote better patient compliance and test results. They are also a lot easier to use for medical professionals